A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer
- H. J. Haisma
- , E. Boven
- , M. Van Muijen
- , J. De Jong
- , W. J F Van der Vijgh
- , H. M. Pinedo
Research output: Contribution to journal › Article › peer-review
98
Link opens in a new tab
Scopus
citations